Inverted aortic bioprosthetic for mitral valve replacement with Ross procedure: case report
Abstract Background A 34-year-old gentleman presented with Staphylococcus salivarius infective endocarditis 13 years after aortic homograft and mitral valve repair for degenerative bicuspid aortic valve associated with rheumatic heart disease. The homograft had calcified, and the mitral repair had d...
Main Authors: | Iain McPherson, Christopher Bayliss, Tommaso Generali, Karen Booth, Asif Hasan |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-02-01
|
Series: | The Cardiothoracic Surgeon |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43057-021-00041-8 |
Similar Items
-
Mid-term outcomes of the COMMENCE trial investigating mitral valve replacement using a bioprosthesis with a novel tissueCentral MessagePerspective
by: David A. Heimansohn, MD, et al.
Published: (2023-09-01) -
Bioprosthetic Valves for Lifetime Management of Aortic Stenosis: Pearls and Pitfalls
by: Konstantinos S. Mylonas, et al.
Published: (2023-11-01) -
Mitral valve replacement after transcatheter aortic valve implantation in a patient with rheumatic heart disease and prior Ross procedure: a case report
by: Khaled D. Algarni, et al.
Published: (2019-11-01) -
Structural hemodynamic valve deterioration durability of RESILIA-tissue versus contemporary aortic bioprostheses
by: Krzysztof Bartus, et al.
Published: (2023-01-01) -
Durability of bioprosthetic aortic valves in patients under the age of 60 years – rationale and design of the international INDURE registry
by: Bart Meuris, et al.
Published: (2020-05-01)